Basel, 23 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive phase I/II data on NXT007 in people with haemophilia A, supporting its progression into phase III clinical development ...
Normalization of DataOps: The "automated deployment, observability, and version control" of real-time systems will become standard, promoting the transition of data engineering from "manual operation" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback